Giorgia Guglielmi
Giorgia Guglielmi is a freelance science writer based in Basel, Switzerland. Specializing in life sciences, medicine, and the relationship between science and society, she has published numerous articles in outlets including Nature, Science, and Scientific American. She holds a PhD in biology from the European Molecular Biology Laboratory and a Master’s in Science Writing from the Massachusetts Institute of Technology. She has received recognition for her work, including the John Kendrew Award in 2020 and an ERC-funded FRONTIERS Media Fellowship in 2025. She has also led lectures and workshops on science communication at institutions such as Harvard University and the University of Zurich.
Gastroenterology
By suggesting that the diversity and variety of microbial species play a big role in whether the transplanted microbes can successfully colonize a recipient’s gut, the findings could pave the…
Gastroenterology
Targeting L-kynurenine metabolism could be a therapeutic strategy for managing Crohn’s disease.
Gastroenterology, Pediatrics
The findings suggest that the composition of the gut microbiota in early life is not a key factor in obesity risk.
Neuroscience
New research has now uncovered differences in the gut microbiota composition between people with the condition and those without.
Oncology
Specific gut microbiota features correlate with better responses to immunotherapy in people with melanoma.
Scientific research
Including microbial load in microbiota studies can help researchers better understand how gut bacteria influence diseases, leading to more accurate diagnoses and effective treatments.
Gastroenterology, Pediatrics
The findings highlight the importance of maintaining a healthy microbiota after EEN and suggest that personalized dietary approaches can help induce remission for children with Crohn’s disease.
Neuroscience, Scientific research
The findings suggest that gut microbes and LPC are potential therapeutic targets for Alzheimer's disease.
Gastroenterology, Scientific research
Researchers have identified a new class of virus-like agents known as "obelisks" in oral and stool samples from hundred of people.
Gynecology
The findings suggest that 4-hydroxyindole could be a promising biomarker for diagnosing endometriosis.